SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
Under the Securities Exchange Act
of 1934
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES
13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT
OF 1934
Horizon Pharmacies, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of
Securities)
439902107
(CUSIP Number)
Check the appropriate box to designate the rule
pursuant to which this Schedule
is filed:
|X| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
Page 1 of 6 Pages
<PAGE>
SCHEDULE 13G
CUSIP No. 439902107
Page 2 of 6 Pages
- - ----------------------------------------------------
- ----------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
GINTEL ASSET MANAGEMENT, INC.
IRS #06-0871969
- - ----------------------------------------------------
- ----------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP (a) [ ]
(b) [X]
GINTEL ASSET MANAGEMENT, INC. 910,000
- - ----------------------------------------------------
- ----------------------------
3) SEC USE ONLY
- - ----------------------------------------------------
- ----------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
- - ----------------------------------------------------
- ----------------------------
5) SOLE VOTING
POWER
910,000
NUMBER -----------------------
- --------------------------
OF 6) SHARED VOTING
POWER
SHARES
BENEFICIALLY -----------------------
- --------------------------
OWNED BY 7) SOLE DISPOSITIVE
POWER
EACH 910,000
REPORTING -----------------------
- --------------------------
PERSON 8) SHARED
DISPOSITIVE POWER
WITH
- - ----------------------------------------------------
- ----------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING
PERSON
910,000
- - ----------------------------------------------------
- ----------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN
SHARES
[ ]
- - ----------------------------------------------------
- ----------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
15.47%
- - ----------------------------------------------------
- ----------------------------
12) TYPE OF REPORTING PERSON
IA
- - ----------------------------------------------------
- ----------------------------
<PAGE>
SCHEDULE 13G
Item 1(a). Name of Issuer:
Horizon Pharmacies, Inc.
Item 1(b). Address of Issuer's Principal Executive
Offices:
501 West Main
Denison, TX 75020
Item 2(a). Name of Person Filing:
GINTEL ASSET MANAGEMENT, INC.
Item 2(b). Address of Principal Business Office or, if
None, Residence:
6 Greenwich Office Park
Greenwich, CT 06831
Item 2(c). Citizenship:
CONNECTICUT CORPORATION
Item 2(d). Title of Class of Securities:
Common Stock $.01 par value
Item 2(e). CUSIP Number:
439902107
Item 3. If this statement is filed pursuant to
ss.ss.240.13d-1(b), or
240.13d-2(b) or (c), check whether the
person filing is a:
(a)|_| Broker or Dealer Registered Under
Section 15 of the Act (15
U.S.C. 78o)
(b)|_| Bank as defined in section
3(a)(6) of the Act (15 U.S.C.
78c)
(c)|_| Insurance Company as defined in
section 3(a)(19) of the Act
(15 U.S.C. 78c)
(d)|_| Investment Company registered
under section 8 of the
Investment Company Act of 1940 (15
U.S.C. 80a-8)
(e)|X| Investment Adviser in
accordance with
ss.240.13d-1(b)(1)(ii)(E)
Page 3 of 5 Pages
<PAGE>
(f)|_| Employee benefit plan or
endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F)
(g)|_| Parent Holding Company or control
person in accordance with
ss.240.13d-1(b)(ii)(G)
(h)|_| Savings Association as defined
in ss.3(b) of the Federal
Deposit Insurance Act (12 U.S.C.
1813)
(i)|_| Church plan that is excluded
from the definition of an
investment company under
ss.3(c)(15) of the Investment
Company Act of 1940 (15 U.S.C.
80a-3)
(j)|_| Group, in accordance with
ss.240.13d-1(b)(ii)(J)
Item 4. Ownership.
Mr. Robert M. Gintel, Chief Executive Officer and
100% shareholder of Gintel
Asset Managment, Inc., is also controlling
partner of Gintel & Co. Limited
Partnership and, Owner of TransAqua L.L.C., and
senior member of Gintel Equity
Managment, L.L.C., which acts as investment advisor to
Gintel Partners Fund.
(a) Amount beneficially owned: 910,000
(b) Percent of class: 15.47%
(c) Number of shares as to which such
person has:
(i) Sole power to vote or to
direct the vote: 910,000
(ii) Shared power to vote or
to direct the vote: -0-
(iii) Sole power to dispose or
to direct the disposition
of: 910,000
(iv) Shared power to
dispose or to direct the
disposition of: -0-
Page 4 of 5 Pages
<PAGE>
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
N/A
Item 7. Identification and Classification of the
Subsidiary Which Acquired
the Security Being Reported on by the Parent
Holding Company.
N/A
Item 8. Identification and Classification of
Members of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification.
By signing below I certify that, to the
best of my knowledge and
belief, the securities referred to above were acquired
in the ordinary course of
business and were not acquired for the purpose of and
do not have the effect of
changing or influencing the control of the issuer of
such securities and were
not acquired in connection with or as a participant
in any transaction having
such purposes or effect.
Page 5 of 6 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best
knowledge and belief of the
undersigned, the undersigned certifies that the
information set forth in this
Statement is true, complete and correct.
GINTEL
ASSET MANAGEMENT, INC.
/s/
Stephen G. Stavrides
---------
- -------------------
BY:
Stephen G. Stavrides
President
DATE: FEBRUARY 10, 2000
Page 6 of 6 Pages
